BRIDGE PHARMA Trademark

Trademark Overview

On Monday, September 9, 2024, a trademark application was filed for BRIDGE PHARMA with the United States Patent and Trademark Office. The USPTO has given the BRIDGE PHARMA trademark a serial number of 98741228. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 9, 2024. This trademark is owned by Bridgewest International Holdings LLC. The BRIDGE PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
bridge pharma

General Information

Serial Number98741228
Word MarkBRIDGE PHARMA
Filing DateMonday, September 9, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBridgewest International Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33131

Trademark Events

Event DateEvent Description
Monday, September 9, 2024NEW APPLICATION ENTERED

Related Keywords

pharma bridge potassium dehydrations levels bleeding pain infection treatment vaccines development research